| Date |
Title |
|
|
July 26, 2021
|
Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
|
|
|
May 10, 2021
|
Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech
|
|
|
May 6, 2021
|
Fulgent Genetics Reports Record First Quarter Financial Results
|
|
|
May 6, 2021
|
Fulgent Genetics Welcomes Dr. Lawrence Weiss as Chief Medical Officer
|
|
|
April 16, 2021
|
Fulgent Genetics to Announce First Quarter 2021 Financial Results on Thursday May 6, 2021
|
|
|
March 15, 2021
|
Fulgent Genetics Awarded Contract from CDC to Study Variants of COVID-19 Virus
|
|
|
March 5, 2021
|
Fulgent Genetics to Participate in the Oppenheimer 31st Annual Healthcare Conference
|
|
|
March 4, 2021
|
Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results
|
|
|
February 18, 2021
|
Fulgent Genetics to Announce Fourth Quarter and Full Year 2020 Financial Results on Thursday March 4, 2021
|
|
|
January 6, 2021
|
Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference
|
|
